Author Question: Identify five major challenges faced when deploying collaboration technologies. What will be an ... (Read 24 times)

bclement10

  • Hero Member
  • *****
  • Posts: 560
Identify five major challenges faced when deploying collaboration technologies.
 
  What will be an ideal response?

Question 2

Each of the following apply to EC in developing economies except
 
  A) developing economies often face power blackouts and unreliable infrastructure and delivery mechanisms creating limitations that make it difficult for firms to predict whether EC investments will pay off, and when.
  B) developing economies, such as China and India, represent a significant opportunity for EC to connect businesses to customers, as well as other businesses.
  C) developing economies struggle with various issues that create too many business and technology risks to justify investment in those economies at this time.
  D) the potential volume of transactions in developed countries can make EC investments more attractive for established firms than new firms because established firms have already recovered the costs of their IT infrastructures.



pratush dev

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

Major challenges include insufficient budget, training end users, ROI difficult to measure, employee resistance, and ensuring security.

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Not getting enough sleep can greatly weaken the immune system. Lack of sleep makes you more likely to catch a cold, or more difficult to fight off an infection.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library